Prosperity Consulting Group »

Enlivex Therapeutics shares owned by Prosperity Consulting Group

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Prosperity Consulting Group from 13F filings

Historical chart of Prosperity Consulting Group investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Prosperity Consulting Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Prosperity Consulting Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 18k 1.04

More positions owned by Prosperity Consulting Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Technology (XLK)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Ultra Short Dur (ICSH)
Ishares Tr Eafe Value Etf (EFV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)

View all positions for Prosperity Consulting Group

Top funds holding Enlivex Therapeutics

Renaissance Technologies
Citadel Advisors
Susquehanna International
XTX Topco
UBS Group
Two Sigma Securities
Sigma Investment Counselors
Jane Street
Hrt Financial
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
Wells Fargo & Company
Group One Trading
Steward Partners Investment Advisory

View all funds holding Enlivex Therapeutics